Pacific Biosciences of California Inc.
PACB | NASDAQ
$1.46
+$0.10 (+7.35%)
Sep 22, 2026, 1:50 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 159.27M | 160.03M | 160.01M | 154.58M | 156.11M | 152.36M | 154.01M | 173.15M | 188.87M | 200.43M | 200.52M | 169.52M | 146.14M | 134.03M | 128.3M | 136.97M | 139.55M | 134.69M | 130.51M | 121.63M | 105.83M | 92.29M |
Cost of Revenue | 101.98M | 100.69M | 114.88M | 116.15M | 122.74M | 127.73M | 116.73M | 136.35M | 144.18M | 146.13M | 147.74M | 121.17M | 102.14M | 89.39M | 79.27M | 76.31M | 77.07M | 74.65M | 71.65M | 68.14M | 60.63M | 54.24M |
Gross Profit | 57.3M | 59.34M | 45.13M | 38.44M | 33.38M | 24.63M | 37.28M | 36.8M | 44.69M | 54.3M | 52.78M | 48.35M | 43.99M | 44.64M | 49.04M | 60.66M | 62.48M | 60.04M | 58.86M | 53.5M | 45.2M | 38.06M |
Operating Income | -162.54M | -162.78M | -553.8M | -665.63M | -690.89M | -821.89M | -474.31M | -408.83M | -427.25M | -324.58M | -334.47M | -334M | -326.13M | -320.93M | -307.2M | -284.79M | -284.64M | -254.25M | -210.44M | -169.74M | -119.44M | -105.39M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -130.56M | -127.77M | -546.06M | -503.2M | -526.31M | -657.73M | -309.54M | -394.96M | -411.81M | -308.32M | -318.16M | -319.81M | -319.2M | -320.76M | -314.25M | -298.02M | -299.33M | -268.94M | -274.87M | -131.78M | -77.21M | -59.29M |
Net Income | -131.39M | -128.58M | -546.38M | -503.63M | -526.36M | -657.75M | -309.85M | -394.24M | -400.38M | -296.9M | -306.74M | -309.1M | -319.2M | -320.76M | -314.25M | -299.19M | -205.68M | -175.29M | -181.22M | -36.96M | -77.21M | -59.29M |
Selling & General & Admin | 129.7M | 132.48M | 141.49M | 148.59M | 161.24M | 160.78M | 163.02M | 167.87M | 167.55M | 172.41M | 169.82M | 168.83M | 162.19M | 160.87M | 160.85M | 153.17M | 147.98M | 137.79M | 124.13M | 104.76M | 87.92M | 73.99M |
Research & Development | 88.36M | 87.86M | 97.31M | 101.89M | 104.56M | 120.52M | 134.92M | 152M | 174M | 181.69M | 187.17M | 185.25M | 184.83M | 189M | 193M | 192.95M | 173.37M | 145.29M | 112.9M | 87.75M | 76.71M | 69.45M |
Other Expenses | 1.85M | 1.85M | 360.19M | 453.65M | 458.47M | 565.21M | 213.66M | 125.76M | 130.39M | 24.79M | 30.26M | 28.28M | 23.11M | 15.7M | 2.38M | -675K | 25.77M | 31.21M | 32.27M | 30.73M | n/a | n/a |
Operating Expenses | 219.83M | 222.12M | 598.93M | 704.07M | 724.27M | 846.51M | 511.6M | 445.63M | 471.94M | 378.88M | 387.25M | 382.35M | 370.13M | 365.57M | 356.23M | 345.45M | 347.12M | 314.29M | 269.3M | 223.23M | 164.63M | 143.44M |
Interest Expense | 3.85M | 3.48M | 6.95M | 7.97M | 9.77M | 11.57M | 13.41M | 14.23M | 14.28M | 14.29M | 14.34M | 14.42M | 14.5M | 14.62M | 14.69M | 14.52M | 14.53M | 14.44M | 12.53M | 9.05M | 5.38M | 1.79M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 321.81M | 322.81M | 713.8M | 820.21M | 847M | 974.24M | 628.33M | 581.98M | 616.12M | 525.01M | 534.99M | 503.52M | 472.27M | 454.96M | 435.5M | 421.76M | 424.19M | 388.94M | 340.95M | 291.37M | 225.26M | 197.68M |
Income Tax Expense | 827K | 804K | 318K | 432K | 49K | 14K | 316K | -718K | -11.42M | -11.42M | -11.42M | -10.71M | n/a | n/a | n/a | 1.18M | -93.65M | -93.65M | -93.65M | -94.82M | n/a | n/a |
Shares Outstanding (Basic) | 310.66M | 305.82M | 301.91M | 300.84M | 300.16M | 296.86M | 283M | 272.92M | 272.39M | 269.58M | 264.86M | 255M | 249.4M | 242.03M | 226.24M | 225.12M | 224.5M | 220.27M | 217.08M | 202.19M | 195.24M | 194.3M |
Shares Outstanding (Diluted) | 310.66M | 305.82M | 301.91M | 300.84M | 300.16M | 296.86M | 306.89M | 272.92M | 272.39M | 269.58M | 267.12M | 255M | 250.07M | 242.03M | 226.24M | 225.12M | 224.5M | 222.29M | 220.73M | 215.13M | 198.57M | 194.79M |
EPS (Basic) | -0.43 | -0.43 | -1.84 | -1.70 | -1.79 | -2.29 | -1.14 | -1.46 | -1.50 | -1.14 | -1.19 | -1.23 | -1.34 | -1.38 | -1.42 | -1.39 | -0.94 | -0.83 | -0.90 | -0.18 | -0.40 | -0.34 |
EPS (Diluted) | -0.43 | -0.43 | -1.84 | -1.70 | -1.79 | -2.29 | -1.14 | -1.46 | -1.50 | -1.14 | -1.19 | -1.23 | -1.34 | -1.38 | -1.42 | -1.38 | -0.93 | -0.82 | -0.89 | -0.21 | -0.43 | -0.37 |
EBITDA | -113.6M | -106.6M | -152.7M | -102.52M | -112.13M | -232.04M | -242.77M | -320.47M | -347.92M | -253.85M | -271.13M | -285.55M | -286.01M | -288.19M | -282.09M | -266.95M | -270M | -241.42M | -250.98M | -113.11M | -62.45M | -48.25M |
EBIT | -126.71M | -124.3M | -539.1M | -495.23M | -516.54M | -646.16M | -296.12M | -380.73M | -397.53M | -294.03M | -303.82M | -304.93M | -304.25M | -305.83M | -299.4M | -283.8M | -285.26M | -254.8M | -262.57M | -122.96M | -71.91M | -57.58M |
Depreciation & Amortization | 13.11M | 17.69M | 386.41M | 392.71M | 404.41M | 414.12M | 53.35M | 60.26M | 49.61M | 40.19M | 32.69M | 19.38M | 18.24M | 17.64M | 17.32M | 16.86M | 15.26M | 13.38M | 11.59M | 9.85M | 9.46M | 9.33M |
Add to Watchlist
Select watchlists to add or remove PACB